Arrowstreet Capital
ARTC

Arrowstreet Capital’s ARTHROCARE CORP ARTC Stock Holding History

Arrowstreet Capital’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-20,364
Closed -$819K – 1523
2013
Q4 		$819K Buy
+20,364
New +$754K ﹤0.01% 869
2013
Q3 		– Sell
-5,633
Closed -$195K – 1196
2013
Q2 		$195K Buy
+5,633
New +$194K ﹤0.01% 722

Other funds holding ARTC

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Arrowstreet Capital's ARTC Position: Q1 2014 in Review

Arrowstreet Capital sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 20,364 shares — an estimated $819K sold.

Arrowstreet Capital first reported a position in ARTC in Q2 2013 and held it in 2 quarters. The position peaked at $819K in Q4 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

  • Arrowstreet Capital reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 20,364 ARTHROCARE CORP shares in Q1 2014, an estimated $819K.
  • Arrowstreet Capital first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 2 quarters.
  • Arrowstreet Capital's ARTHROCARE CORP position peaked at $819K in Q4 2013.
  • 117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.